ZA991489B - Oxaliplatin solution formulations and the method of use thereof. - Google Patents
Oxaliplatin solution formulations and the method of use thereof.Info
- Publication number
- ZA991489B ZA991489B ZA9901489A ZA991489A ZA991489B ZA 991489 B ZA991489 B ZA 991489B ZA 9901489 A ZA9901489 A ZA 9901489A ZA 991489 A ZA991489 A ZA 991489A ZA 991489 B ZA991489 B ZA 991489B
- Authority
- ZA
- South Africa
- Prior art keywords
- solution formulations
- oxaliplatin solution
- oxaliplatin
- formulations
- solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9804013.2A GB9804013D0 (en) | 1998-02-25 | 1998-02-25 | Formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA991489B true ZA991489B (en) | 1999-09-30 |
Family
ID=10827600
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9901489A ZA991489B (en) | 1998-02-25 | 1999-02-24 | Oxaliplatin solution formulations and the method of use thereof. |
Country Status (28)
Country | Link |
---|---|
US (1) | US6306902B1 (fr) |
EP (1) | EP0943331B1 (fr) |
JP (1) | JP4430229B2 (fr) |
KR (1) | KR20010041182A (fr) |
CN (1) | CN1152718C (fr) |
AR (1) | AR015524A1 (fr) |
AT (1) | ATE202472T1 (fr) |
AU (1) | AU757101B2 (fr) |
BR (1) | BR9908273A (fr) |
CA (1) | CA2261500C (fr) |
CZ (1) | CZ302196B6 (fr) |
DE (1) | DE69900162T2 (fr) |
DK (1) | DK0943331T3 (fr) |
ES (1) | ES2161085T3 (fr) |
GB (1) | GB9804013D0 (fr) |
GR (1) | GR3036646T3 (fr) |
GT (1) | GT199900019A (fr) |
HK (1) | HK1036405A1 (fr) |
HU (1) | HU224611B1 (fr) |
IL (1) | IL137772A (fr) |
MX (1) | MXPA00008195A (fr) |
NO (1) | NO329900B1 (fr) |
PL (1) | PL197948B1 (fr) |
PT (1) | PT943331E (fr) |
RU (1) | RU2207857C2 (fr) |
UA (1) | UA70316C2 (fr) |
WO (1) | WO1999043355A2 (fr) |
ZA (1) | ZA991489B (fr) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9804013D0 (en) | 1998-02-25 | 1998-04-22 | Sanofi Sa | Formulations |
CA2346564C (fr) * | 1998-10-14 | 2011-05-03 | Debiopharm S.A. | Conditionnement d'une preparation d'oxaliplatine |
WO2001015691A1 (fr) * | 1999-08-30 | 2001-03-08 | Debiopharm S.A. | Preparation pharmaceutique stable d'oxaliplatine pour administration par voie parenterale |
US7070796B1 (en) | 1999-08-30 | 2006-07-04 | Debiopharm S.A. | Pharmaceutically stable oxaliplatinum preparation for parenteral administration |
US7012072B2 (en) * | 2000-12-12 | 2006-03-14 | Debiopharm S.A. | Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same |
WO2002069959A1 (fr) | 2001-03-02 | 2002-09-12 | Debiopharm S.A. | Dispositif de conditionnement d'une solution d'oxaliplatine |
EP1404689A1 (fr) | 2001-07-02 | 2004-04-07 | Debiopharm S.A. | Substance active a base d'oxaliplatine presentant une faible teneur en acide oxalique |
US6476068B1 (en) * | 2001-12-06 | 2002-11-05 | Pharmacia Italia, S.P.A. | Platinum derivative pharmaceutical formulations |
CA2388352A1 (fr) * | 2002-05-31 | 2003-11-30 | Voiceage Corporation | Methode et dispositif pour l'amelioration selective en frequence de la hauteur de la parole synthetisee |
DE10314377A1 (de) * | 2003-03-28 | 2004-10-07 | Stada Arzneimittel Ag | Gebrauchsfertige Oxaliplatin-Lösungen |
US20050020556A1 (en) * | 2003-05-30 | 2005-01-27 | Kosan Biosciences, Inc. | Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes |
GB2441445B (en) * | 2003-08-28 | 2008-04-23 | Mayne Pharma Ltd | Acid containing oxaliplatin formulation |
NZ545591A (en) * | 2003-08-28 | 2008-11-28 | Mayne Pharma Ltd | Acid containing oxaliplatin formulations |
JP2007504177A (ja) * | 2003-09-02 | 2007-03-01 | プリヴァ−ラケマ,エー.エス. | 医薬組成物、その製造方法及び治療上の使用 |
CZ300795B6 (cs) * | 2003-09-02 | 2009-08-12 | Pliva-Lachema A. S. | Farmaceutická kompozice a zpusob její výroby |
US7576126B2 (en) | 2003-11-25 | 2009-08-18 | Platco Technologies (Proprietary) Limited | Platinum (II) complexes, preparation and use |
CN100471493C (zh) * | 2003-12-17 | 2009-03-25 | 梅比欧法姆股份有限公司 | 含有奥沙利铂的脂质体制剂 |
WO2005102312A1 (fr) * | 2004-04-27 | 2005-11-03 | Mayne Pharma Limited | Solutions concentrees d'oxaliplatine |
EP2011798B1 (fr) | 2004-09-01 | 2011-06-29 | Platco Technologies (Proprietary) Limited | Préparation de complexes de platine (II) |
US20060063720A1 (en) * | 2004-09-22 | 2006-03-23 | Edgar Schridde | Oxaliplatin solution concentrate |
US20060063833A1 (en) * | 2004-09-22 | 2006-03-23 | Edgar Schridde | Ready-to-use oxaliplatin solutions |
DE102004052877B4 (de) * | 2004-11-02 | 2008-06-19 | Ebewe Pharma Ges.M.B.H. Nfg.Kg | Stabile wässrige Formulierungen eines Platin-Derivats |
DE102004063764A1 (de) * | 2004-12-29 | 2006-07-13 | Hexal Ag | Kunststoff-Flasche für Oxaliplatin |
JP2006248978A (ja) | 2005-03-10 | 2006-09-21 | Mebiopharm Co Ltd | 新規なリポソーム製剤 |
ATE430564T1 (de) * | 2005-03-28 | 2009-05-15 | Dabur Pharma Ltd | Stabile pharmazeutische zusammensetzungen aus antitumoralen platin-(ii)-mitteln |
CA2604862A1 (fr) * | 2005-04-09 | 2006-10-19 | Vuab Pharma A.S. | Procede de realisation d'une preparation a base d'oxalyplatine |
DE102005038347A1 (de) * | 2005-08-11 | 2007-02-15 | Hexal Ag | Herstellung einer Oxaliplatin-Lösung und Behälter sowie Behälter-Set mit der Lösung |
WO2007029268A2 (fr) * | 2005-09-05 | 2007-03-15 | Dabur Pharma Limited | Formulation stable d'oxaliplatine |
CN101389637A (zh) | 2006-01-30 | 2009-03-18 | 普拉托技术(私有)公司 | 铂(ⅱ)配合物的制备 |
KR100913063B1 (ko) | 2006-09-13 | 2009-08-21 | 주식회사유한양행 | 옥살리플라틴-함유 주사용 용액 |
US20100093849A1 (en) * | 2007-01-22 | 2010-04-15 | Borek Zaludek | Oxaliplatin pharmaceutical composition with alcoholic sugar-based buffer |
EP2152239A1 (fr) * | 2007-11-12 | 2010-02-17 | Intas Pharmaceuticals Limited | Composition d'oxaliplatine stable pour une administration parentérale |
US20090130017A1 (en) * | 2007-11-19 | 2009-05-21 | Searete Llc | Targeted short-lived drug delivery |
WO2010056847A2 (fr) * | 2008-11-13 | 2010-05-20 | Taigen Biotechnology Co., Ltd. | Formule lyophilisée |
CN101461801B (zh) * | 2008-12-26 | 2013-05-15 | 辰欣药业股份有限公司 | 一种奥沙利铂药物组合物及其制备方法 |
EP2481396A4 (fr) | 2009-09-21 | 2014-03-05 | Jw Pharmaceutical Corp | Nanoparticules d'oxaliplatine et leur procédé de préparation |
CN102274171A (zh) * | 2011-08-04 | 2011-12-14 | 上海希迪制药有限公司 | 一种奥沙利铂注射剂 |
CN104523674B (zh) * | 2014-12-11 | 2017-10-24 | 广州市上为医药科技有限公司 | 一种以奥沙利铂为主药成分的注射用组合物 |
KR101683635B1 (ko) | 2014-12-29 | 2016-12-09 | 가천대학교 산학협력단 | 락테이트 금속염을 포함하는 암 치료용 약학 조성물 |
CN104829653B (zh) * | 2015-05-06 | 2016-03-23 | 山东罗欣药业集团股份有限公司 | 一种奥沙利铂水合物晶体及其冻干粉针剂 |
TWI827577B (zh) | 2018-01-12 | 2024-01-01 | 南韓商梅堤梅蒂製藥有限公司 | 治療慢性發炎疾病的方法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6041077B2 (ja) * | 1976-09-06 | 1985-09-13 | 喜徳 喜谷 | 1,2‐ジアミノシクロヘキサン異性体のシス白金(2)錯体 |
PT93772A (pt) | 1989-04-17 | 1991-01-08 | Searle & Co | Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer |
EP0464210A4 (en) | 1989-12-15 | 1992-11-25 | Tsumura & Co. | Novel platinum complex and antitumor drug containing the same as active ingredient |
JPH04185601A (ja) * | 1990-11-20 | 1992-07-02 | Unitika Ltd | 白金抗癌剤徐放性製剤 |
AU671605B2 (en) * | 1991-11-15 | 1996-09-05 | Smithkline Beecham Corporation | Combination chemotherapy |
JPH0776230B2 (ja) * | 1992-01-13 | 1995-08-16 | 田中貴金属工業株式会社 | 白金化合物の製造方法 |
JPH05238936A (ja) | 1992-02-27 | 1993-09-17 | Dainippon Pharmaceut Co Ltd | カルシトリオールの水性液剤 |
JP2673331B2 (ja) * | 1993-01-12 | 1997-11-05 | 田中貴金属工業 株式会社 | 光学的に高純度なシス―オキザラート(トランス―1―1,2―シクロヘキサンジアミン)白金(▲ii▼) |
JPH06287021A (ja) * | 1992-04-22 | 1994-10-11 | Tanaka Kikinzoku Kogyo Kk | 光学活性な白金錯化合物の光学的分割方法 |
AU5416394A (en) * | 1992-11-24 | 1994-06-22 | Debiopharm S.A. | Cisplatinum/oxaliplatinum combination |
JP3025602B2 (ja) * | 1993-05-21 | 2000-03-27 | デビオファーム エス.アー. | 光学的に高純度なシス−オキザラート(トランス−l−1,2−シクロヘキサンジアミン)白金(II)錯体の製造方法 |
US5455270A (en) * | 1993-08-11 | 1995-10-03 | Bristol-Myers Squibb Co. | Stabilized solutions of platinum(II) antitumor agents |
ES2152412T3 (es) | 1994-08-08 | 2001-02-01 | Debiopharm Sa | Preparacion farmaceuticamente estable de oxaliplatino. |
ES2206478T3 (es) * | 1994-11-11 | 2004-05-16 | Debiopharm S.A. | Composiciones carcinostaticas que contienen cis-oxaliplatino y otra u otras sustancias carcinostaticas compatibles. |
FR2740686B1 (fr) * | 1995-11-03 | 1998-01-16 | Sanofi Sa | Formulation pharmaceutique lyophilisee stable |
DK0801070T3 (da) | 1996-04-10 | 2003-05-19 | Debiopharm Sa | Fremgangsmåde til fremstilling af platinforbindelse |
JPH09294809A (ja) | 1996-05-07 | 1997-11-18 | Terumo Corp | 薬液注入器具 |
GB9804013D0 (en) | 1998-02-25 | 1998-04-22 | Sanofi Sa | Formulations |
-
1998
- 1998-02-25 GB GBGB9804013.2A patent/GB9804013D0/en not_active Ceased
-
1999
- 1999-02-11 GT GT199900019A patent/GT199900019A/es unknown
- 1999-02-11 CA CA002261500A patent/CA2261500C/fr not_active Expired - Lifetime
- 1999-02-22 US US09/255,087 patent/US6306902B1/en not_active Expired - Lifetime
- 1999-02-24 AR ARP990100774A patent/AR015524A1/es active IP Right Grant
- 1999-02-24 ZA ZA9901489A patent/ZA991489B/xx unknown
- 1999-02-25 MX MXPA00008195A patent/MXPA00008195A/es active IP Right Grant
- 1999-02-25 DK DK99301412T patent/DK0943331T3/da active
- 1999-02-25 CZ CZ20003089A patent/CZ302196B6/cs not_active IP Right Cessation
- 1999-02-25 PL PL343021A patent/PL197948B1/pl unknown
- 1999-02-25 AU AU26324/99A patent/AU757101B2/en not_active Expired
- 1999-02-25 ES ES99301412T patent/ES2161085T3/es not_active Expired - Lifetime
- 1999-02-25 DE DE69900162T patent/DE69900162T2/de not_active Ceased
- 1999-02-25 AT AT99301412T patent/ATE202472T1/de active
- 1999-02-25 BR BR9908273-0A patent/BR9908273A/pt not_active Application Discontinuation
- 1999-02-25 CN CNB99803276XA patent/CN1152718C/zh not_active Expired - Lifetime
- 1999-02-25 RU RU2000121254/14A patent/RU2207857C2/ru active
- 1999-02-25 JP JP2000533150A patent/JP4430229B2/ja not_active Expired - Lifetime
- 1999-02-25 UA UA2000095450A patent/UA70316C2/uk unknown
- 1999-02-25 EP EP99301412A patent/EP0943331B1/fr not_active Expired - Lifetime
- 1999-02-25 PT PT99301412T patent/PT943331E/pt unknown
- 1999-02-25 HU HU0103707A patent/HU224611B1/hu active IP Right Grant
- 1999-02-25 KR KR1020007009239A patent/KR20010041182A/ko active Search and Examination
- 1999-02-25 WO PCT/GB1999/000572 patent/WO1999043355A2/fr not_active Application Discontinuation
-
2000
- 2000-08-09 IL IL137772A patent/IL137772A/en not_active IP Right Cessation
- 2000-08-24 NO NO20004240A patent/NO329900B1/no not_active IP Right Cessation
-
2001
- 2001-09-18 GR GR20010401504T patent/GR3036646T3/el unknown
- 2001-10-16 HK HK01107235A patent/HK1036405A1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA991489B (en) | Oxaliplatin solution formulations and the method of use thereof. | |
HUP9900163A2 (en) | Process for the preparation of sterol-and stanol-esters, and use thereof | |
ZA991951B (en) | Compound and its use. | |
HK1019774A1 (en) | Etching composition and use thereof. | |
IL133531A0 (en) | 4-haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclylpyridines, method for the production thereof, agents containing the same and their use as pesticides | |
HK1042084A1 (en) | Substituted benzimidazoles and their preparation and use. | |
ZA200007641B (en) | Treatment of airborne allergens. | |
HK1034722A1 (en) | Antipicornaviral compounds, their preparation and use | |
HUP9904104A3 (en) | Derivates from piperidine-keto acid,their preparation and use | |
HK1041827A1 (en) | Compounds for the treatment of estrogen-defendent illnesses and methods for making and using the dame. | |
HUP0203611A3 (en) | 14,15-beta-methylene substituted androgens and their use for preparation of the medicaments | |
GB9811168D0 (en) | Direct hair-colouring compositions and the use thereof | |
ZA200006206B (en) | Benzazole compounds and their use. | |
ZA200004865B (en) | Heat transpiration preparation and method of the heat transpiration of chemical by using the same. | |
ZA200006020B (en) | Voacamine as anti-malarial agent and anti-malarial agent containing voacamine. | |
HUP0102226A3 (en) | Hyperforin derivatives, the use thereof and formulations containing them | |
GB9815312D0 (en) | Biomas treatment | |
PL345017A1 (en) | Coatings agent and the use thereof | |
ZA991231B (en) | Skin care compositions. | |
IL133481A0 (en) | Substituted cycloheptenes, their preparation and use | |
ZA200109120B (en) | Use of Arylalkanoylpyridazines. | |
AU3061199A (en) | Skin treatment compositions and the use thereof | |
EP1032266A4 (fr) | Utilisation de delta5-androstene-3beta-ol-7,17-dione dans le traitement de l'arthrite | |
ZA995262B (en) | Massage composition and method. | |
FI973631A (fi) | 1,3-diolipohjaiset eetterit, menetelmä 1,3-diolipohjaisten eetterien valmistamiseksi sekä eetterien käyttö |